J7303 HCPCS code: Contraceptive supply, hormone containing vaginal ring, each
J7303 is the HCPCS Level II code for contraceptive supply, hormone containing vaginal ring, each. CMS terminated J7303 on 2021-09-30; do not bill it for later dates of service. Its Medicare coverage code is S (Non-covered by Medicare statute): Medicare is barred by law from covering it.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | S — Non-covered by Medicare statute |
| Pricing indicator | 00 — Not separately priced by Medicare |
| BETOS category | Z2 |
| Added | 2004-01-01 |
| Last action effective | 2021-10-01 |
| Terminated | 2021-09-30 |
What changed for J7303
- 2004-01-01: J7303 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J7303?
J7303 is the HCPCS Level II code for contraceptive supply, hormone containing vaginal ring, each. Short descriptor: "Contraceptive vaginal ring".
Does Medicare cover J7303?
Coverage code S — Non-covered by Medicare statute. Medicare is barred by law from covering it.
Related J73 codes
- J7300 — Intrauterine copper contraceptive (paragard)
- J7301 — Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg
- J7302 — Levonorgestrel-releasing intrauterine contraceptive system, 52 mg
- J7304 — Contraceptive supply, hormone containing patch, each
- J7306 — Levonorgestrel (contraceptive) implant system, including implants and supplies
- J7307 — Etonogestrel (contraceptive) implant system, including implant and supplies
- J7308 — Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)
- J7309 — Methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gram
- J7310 — Ganciclovir, 4.5 mg, long-acting implant
- J7311 — Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg
- J7312 — Injection, dexamethasone, intravitreal implant, 0.1 mg
- J7313 — Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J7303
- Watch J7303 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J7303
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.